Monkeypox: From Emerging Trends to Therapeutic Concerns
- PMID: 38800170
- PMCID: PMC11116278
- DOI: 10.7759/cureus.58866
Monkeypox: From Emerging Trends to Therapeutic Concerns
Abstract
Monkeypox is a zoonotic viral disease. Monkeypox was first reported in humans about 54 years ago. Prior to the global outbreak, monkeypox was endemic to the rainforests of central and western African countries. In the last three years, increasing numbers of human monkeypox have been reported from various countries. Responding to the severity, monkeypox was declared a Public Health Emergency of International Concern by the World Health Organization. In the absence of approved drugs or clinical studies, repurposed drugs and therapeutic medical countermeasures effective against other orthopoxviruses have been utilized to treat severe human monkeypox cases. Currently, clinical trials are underway exploring the potential therapeutic effectiveness of tecovirimate in human monkeypox cases. Monoclonal antibodies, IFN-β, resveratrol, and 15 triple-targeting FDA-approved drugs represent potential new drug targets for human monkeypox, necessitating further research.
Keywords: bcv; hmxpv; mpox; oxpv; pheic; tecovirimat; vigiv.
Copyright © 2024, Piparva et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Monkeypox: An Emerging Global Public Health Emergency.Life (Basel). 2022 Oct 12;12(10):1590. doi: 10.3390/life12101590. Life (Basel). 2022. PMID: 36295025 Free PMC article. Review.
-
Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.J Med Virol. 2023 Apr;95(4):e28701. doi: 10.1002/jmv.28701. J Med Virol. 2023. PMID: 36951352 Review.
-
Global Outbreak of Human Monkeypox in 2022: Update of Epidemiology.Trop Med Infect Dis. 2022 Sep 25;7(10):264. doi: 10.3390/tropicalmed7100264. Trop Med Infect Dis. 2022. PMID: 36288005 Free PMC article. Review.
-
Emerging pharmacological strategies for treating and preventing mpox.Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(9):843-854. doi: 10.1080/17512433.2023.2249820. Epub 2023 Aug 22. Expert Rev Clin Pharmacol. 2023. PMID: 37592723 Review.
-
Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.MMWR Morb Mortal Wkly Rep. 2023 Mar 3;72(9):232-243. doi: 10.15585/mmwr.mm7209a4. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36862595 Free PMC article.
Cited by
-
Virology, epidemiology, transmissions, diagnostic tests, prophylaxis and treatments of human Mpox: Saudi Arabia perspective.Front Cell Infect Microbiol. 2025 Feb 28;15:1530900. doi: 10.3389/fcimb.2025.1530900. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40093536 Free PMC article. Review.
-
What every intensivist needs to know about mpox.Crit Care. 2024 Nov 4;28(1):356. doi: 10.1186/s13054-024-05114-8. Crit Care. 2024. PMID: 39497208 Free PMC article. No abstract available.
-
Mpox: Global epidemic situation and countermeasures.Virulence. 2025 Dec;16(1):2457958. doi: 10.1080/21505594.2025.2457958. Epub 2025 Feb 8. Virulence. 2025. PMID: 39921615 Free PMC article. Review.
References
-
- A pox-like disease in cynomolgus monkeys. Magnus VP, Anderson EK, Petersen KB, Birch-Andersen A. https://doi.org/10.1111/j.1699-0463.1959.tb00328.x Acta Pathol Microbiol Scand. 1959;46:156–176.
-
- The transmission potential of monkeypox virus in human populations. Fine PE, Jezek Z, Grab B, Dixon H. Int J Epidemiol. 1988;10:1093. - PubMed
-
- A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Ladnyj ID, Ziegler P, Kima E. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480792/ Bull World Health Organ. 1972;46:593–597. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources